• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊癌中雌性激素受体、结缔组织生长因子和 HER2 的表达。

Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.

机构信息

Department of Oncology, Military Institute of Medicine, Warsaw, Poland.

Mazovian Center for Lung Diseases and Tuberculosis, Division III in Otwock, Otwock, Poland.

出版信息

Sci Rep. 2020 Feb 5;10(1):1871. doi: 10.1038/s41598-020-58777-y.

DOI:10.1038/s41598-020-58777-y
PMID:32024900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7002405/
Abstract

Gallbladder cancer (GBC) is a highly malignant tumor with poorly understood etiology. An insight into phenotypic features of this malignancy may add to the knowledge of its carcinogenesis and pave the way to new therapeutic approaches. We assessed the expression of female sex hormone receptors (ERα, ERβ, PR), connective tissue growth factor (CTGF) and HER2 in GBC, and adjacent normal tissue (NT), and determined their prognostic impact. Immunohistochemical (IHC) expression of all biomarkers was performed in formalin-fixed, paraffin-embedded specimens in 60 Caucasian GBC patients (51 women and 9 men). ERβ, cytoPR and CTGF expression were found in 89%, 27%, 91% of GBC, and in 63%, 87%, 100% of NT, respectively. No ERα expression was found in GBC and NT. Strong (3+) HER2 expression by IHC or HER2 amplification was seen in five GBC (10.4%). A positive correlation was found between HER2 and CTGF and ERβ expression in GBC and matched NT. In the multivariate analysis, patient age >70 years, tumor size and ERβ expression in GBC was highly predictive for OS (p = 0.003). The correlation between HER2, CTGF and ERβ expression in GBC and NT may indicate the interaction of these pathways in physiological processes and gallbladder pathology.

摘要

胆囊癌(GBC)是一种恶性程度很高的肿瘤,其病因尚不清楚。深入了解这种恶性肿瘤的表型特征可能有助于了解其致癌机制,并为新的治疗方法铺平道路。我们评估了女性性激素受体(ERα、ERβ、PR)、结缔组织生长因子(CTGF)和 HER2 在 GBC 及相邻正常组织(NT)中的表达,并确定了它们的预后影响。在 60 名高加索 GBC 患者(51 名女性和 9 名男性)的福尔马林固定、石蜡包埋标本中进行了所有生物标志物的免疫组织化学(IHC)表达分析。在 GBC 中发现 ERβ、细胞 PR 和 CTGF 的表达分别为 89%、27%、91%,在 NT 中分别为 63%、87%、100%。在 GBC 和 NT 中均未发现 ERα 表达。IHC 或 HER2 扩增显示 5 例 GBC(10.4%)存在强(3+)HER2 表达。在 GBC 和匹配的 NT 中,HER2 与 CTGF 和 ERβ 表达之间存在正相关。在多变量分析中,患者年龄>70 岁、肿瘤大小和 GBC 中的 ERβ 表达是 OS 的高度预测因素(p=0.003)。GBC 和 NT 中 HER2、CTGF 和 ERβ 表达之间的相关性可能表明这些途径在生理过程和胆囊病理中的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/367e/7002405/a0965e78fa02/41598_2020_58777_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/367e/7002405/2f531a5eb4ab/41598_2020_58777_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/367e/7002405/a0965e78fa02/41598_2020_58777_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/367e/7002405/2f531a5eb4ab/41598_2020_58777_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/367e/7002405/a0965e78fa02/41598_2020_58777_Fig2_HTML.jpg

相似文献

1
Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.胆囊癌中雌性激素受体、结缔组织生长因子和 HER2 的表达。
Sci Rep. 2020 Feb 5;10(1):1871. doi: 10.1038/s41598-020-58777-y.
2
Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.结缔组织生长因子免疫组化表达与胆囊癌进展相关。
Arch Pathol Lab Med. 2013 Feb;137(2):245-50. doi: 10.5858/arpa.2011-0628-OA.
3
Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.基因表达系列分析确定结缔组织生长因子表达为胆囊癌的一种预后生物标志物。
Clin Cancer Res. 2008 May 1;14(9):2631-8. doi: 10.1158/1078-0432.CCR-07-1991.
4
Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.人表皮生长因子受体(Her 2/neu)与增殖标志物Ki-67的表达:与胆囊癌临床病理参数的关系
Asian Pac J Cancer Prev. 2016;17(8):3903-9.
5
Expression Pattern of Estrogen Receptor Alpha and Progesterone Receptor in Gallbladder Carcinoma and Their Association with Clinicopathological Parameters and Overall Survival.胆囊癌中雌激素受体α和孕激素受体的表达模式及其与临床病理参数和总生存的关系。
J Gastrointest Cancer. 2024 Sep;55(3):1154-1164. doi: 10.1007/s12029-024-01045-3. Epub 2024 May 18.
6
A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.可切除胆囊癌患者中有相当一部分亚组为HER2阳性状态。
Virchows Arch. 2016 Apr;468(4):431-9. doi: 10.1007/s00428-015-1898-1. Epub 2016 Jan 13.
7
Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.胆囊鳞癌/腺鳞癌及胆囊腺癌的临床病理特征与CCT2和PDIA2表达
World J Surg Oncol. 2013 Jun 19;11:143. doi: 10.1186/1477-7819-11-143.
8
Expression of HER2 and bradykinin B₁ receptors in precursor lesions of gallbladder carcinoma.胆囊癌前病变中 HER2 和缓激肽 B1 受体的表达。
World J Gastroenterol. 2012 Mar 21;18(11):1208-15. doi: 10.3748/wjg.v18.i11.1208.
9
Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker.层粘连蛋白 (14-3-3sigma) 在胆囊腺癌中的作用:一种新的预后生物标志物。
Surg Oncol. 2020 Mar;32:57-62. doi: 10.1016/j.suronc.2019.10.022. Epub 2019 Nov 2.
10
Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma.胆囊癌中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER-2 Neu)的表达及其与肿瘤标志物的相关性
J Cancer Res Ther. 2023 Jul-Sep;19(5):1279-1287. doi: 10.4103/jcrt.jcrt_1754_21.

引用本文的文献

1
Human epidermal growth factor receptor-2/neu expression in gallbladder cancer is significantly associated with clinicopathological parameters and survival.人类表皮生长因子受体2/neu在胆囊癌中的表达与临床病理参数及生存情况显著相关。
Indian J Gastroenterol. 2025 Feb 3. doi: 10.1007/s12664-024-01723-x.
2
Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights.心血管代谢综合征与胆道癌的相互作用:一项具有性别特异性见解的综合分析。
Cancers (Basel). 2024 Oct 9;16(19):3432. doi: 10.3390/cancers16193432.
3
Clinicopathological Significance of Cell Adhesion Molecule 4 Expression in Gallbladder Cancer and Its Prognostic Role.

本文引用的文献

1
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.抗体偶联药物 ado-trastuzumab emtansine 治疗 HER2 突变型肺癌患者的疗效:一项 II 期篮子试验的结果。
J Clin Oncol. 2018 Aug 20;36(24):2532-2537. doi: 10.1200/JCO.2018.77.9777. Epub 2018 Jul 10.
2
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.曲妥珠单抗治疗 HER2 和 HER3 突变型癌症患者的 HER 激酶抑制作用。
Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31.
3
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
胆囊癌中细胞黏附分子 4 表达的临床病理意义及其预后作用。
Int J Mol Sci. 2023 Apr 7;24(8):6898. doi: 10.3390/ijms24086898.
4
Establishment and characterization of an immortalized epithelial cell line from human gallbladder.人胆囊永生化上皮细胞系的建立与鉴定
Front Oncol. 2022 Oct 28;12:994087. doi: 10.3389/fonc.2022.994087. eCollection 2022.
5
The Prognostic Value of Estrogen Receptor β Isoform With Correlation of Estrogen Receptor α Among Sudanese Breast Cancer Patients.苏丹乳腺癌患者中雌激素受体β亚型的预后价值及其与雌激素受体α的相关性
Breast Cancer (Auckl). 2021 Feb 25;15:1178223421998354. doi: 10.1177/1178223421998354. eCollection 2021.
6
Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling.通过分泌组分析鉴定乳腺癌浸润的驱动因素:对 CTGF 信号的深入了解。
Sci Rep. 2020 Oct 21;10(1):17889. doi: 10.1038/s41598-020-74838-8.
胆管癌的基因组特征分析确定了驱动基因和易感性突变。
J Hepatol. 2018 May;68(5):959-969. doi: 10.1016/j.jhep.2018.01.009. Epub 2018 Jan 31.
4
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.基于分子谱的晚期实体瘤的靶向治疗:MyPathway 研究的结果,一项开放标签、Ⅱa 期多篮子研究。
J Clin Oncol. 2018 Feb 20;36(6):536-542. doi: 10.1200/JCO.2017.75.3780. Epub 2018 Jan 10.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations.胆囊癌的靶向基因测序鉴定出高影响性的体细胞和罕见种系突变。
Cancer Genomics Proteomics. 2017 Nov-Dec;14(6):495-506. doi: 10.21873/cgp.20059.
7
Prognostic Significance of HER-2 and p53 Expression in Gallbladder Carcinoma in North Indian Patients.HER-2和p53表达在北印度胆囊癌患者中的预后意义
Oncology. 2016;91(6):354-360. doi: 10.1159/000450999. Epub 2016 Oct 27.
8
Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.人表皮生长因子受体(Her 2/neu)与增殖标志物Ki-67的表达:与胆囊癌临床病理参数的关系
Asian Pac J Cancer Prev. 2016;17(8):3903-9.
9
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.血浆 ESR1 突变与雌激素受体阳性晚期乳腺癌的治疗。
J Clin Oncol. 2016 Sep 1;34(25):2961-8. doi: 10.1200/JCO.2016.67.3061. Epub 2016 Jun 6.
10
The inflammatory inception of gallbladder cancer.胆囊癌的炎症起源
Biochim Biophys Acta. 2016 Apr;1865(2):245-54. doi: 10.1016/j.bbcan.2016.03.004. Epub 2016 Mar 12.